Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220

Cancer Incidence in Five Continents

(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

Ferlay, J., Steliarova‐Foucher, E., Lortet‐Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H., Forman, D., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.027 · Cited by 5,243

Global burden of cancers attributable to infections in 2012: a synthetic analysis

Plummer, M., de Martel, C., Vignat, J., Ferlay, J., Bray, F., & Franceschi, S. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30143-7 · Cited by 1,634

United Nations Population Division

Wheldon, M. C., Raftery, A. E., Clark, S. J., & Gerland, P. (2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_6852 · Cited by 982

Cancer mortality for selected sites in 24 countries

栗原, 登., & 瀬木, 三. (1960) · Medical Entomology and Zoology · Cited by 880

Guidelines for accurate and transparent health estimates reporting: the GATHER statement

Stevens, G. A., Alkema, L., Black, R. E., Boerma, J. T., Collins, G. S., Ezzati, M., Grove, J. T., Hogan, D. R., Hogan, M. C., Horton, R., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002056 · Cited by 424

Genetic Landscape of Papillary Thyroid Carcinoma and Nuclear Architecture: An Overview Comparing Pediatric and Adult Populations

Pozzo, A. R., Sisdelli, L., Cordioli, M. I. C. V., Vaisman, F., Caria, P., Mai, S., & Cerutti, J. M. (2020) · Cancers · doi:10.3390/cancers12113146 · Cited by 74

Green Synthesis and Biomedical Applications of ZnO Nanoparticles: Role of PEGylated-ZnO Nanoparticles as Doxorubicin Drug Carrier against MDA-MB-231(TNBC) Cells Line

Batool, M., Khurshid, S., Daoush, W. M., Siddique, S. A., & Nadeem, T. (2021) · Crystals · doi:10.3390/cryst11040344 · Cited by 75

The role of hypoxia on prostate cancer progression and metastasis

Mohamed, O. A. A., Tesen, H. S., Hany, M., Sherif, A., Abdelwahab, M. M., & Elnaggar, M. H. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08251-5 · Cited by 81

The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer

Wang, S., Qiu, Y., & Bai, B. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00614 · Cited by 74

Automatic segmentation of whole-slide H&E stained breast histopathology images using a deep convolutional neural network architecture

Priego, B., Morillo, D., Fernandez-Granero, M. A., & García‐Rojo, M. (2020) · Expert Systems with Applications · doi:10.1016/j.eswa.2020.113387 · Cited by 73

25-Hydroxyvitamin D status, vitamin D intake, and skin cancer risk: a systematic review and dose–response meta-analysis of prospective studies

Mahamat‐Saleh, Y., Aune, D., & Schlesinger, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-70078-y · Cited by 72

Surprising impact of stromal TIL’s on immunotherapy efficacy in a real-world lung cancer study

Hashemi, S. M. S., Fransen, M. F., Niemeijer, A.-L. N., Taleb, N., Houda, I., Veltman, J. D., Becker‐Commissaris, A., Daniels, J. M. A., Crombag, L. M. M. J., Radonic, T., et al. (2021) · Lung Cancer · doi:10.1016/j.lungcan.2021.01.013 · Cited by 76

Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis

Bonjour, M., Charvat, H., Franco, E. L., Piñeros, M., Clifford, G. M., Bray, F., & Baussano, I. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00046-3 · Cited by 73

CT Body Composition of Sarcopenia and Sarcopenic Obesity: Predictors of Postoperative Complications and Survival in Patients with Locally Advanced Esophageal Adenocarcinoma

Fehrenbach, U., Wuensch, T., Gabriel, P., Segger, L., Yamaguchi, T., Auer, T. A., Beetz, N. L., Denecke, C., Kröll, D., Raakow, J., et al. (2021) · Cancers · doi:10.3390/cancers13122921 · Cited by 75

Heterochiral β-Peptide Polymers Combating Multidrug-Resistant Cancers Effectively without Inducing Drug Resistance

Shao, N., Yuan, L., Ma, P., Zhou, M., Xiao, X., Cong, Z., Wu, Y., Xiao, G., Fei, J., & Liu, R. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c00452 · Cited by 73

Saliva Based Liquid Biopsies in Head and Neck Cancer: How Far Are We From the Clinic?

Patel, A., Patel, S., Patel, P., & Tanavde, V. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.828434 · Cited by 73

Sustainable bioactivity enhancement of ZnO–Ag nanoparticles in antimicrobial, antibiofilm, lung cancer, and photocatalytic applications

Dutta, G., Chinnaiyan, S. K., Sugumaran, A., & Narayanasamy, D. (2023) · RSC Advances · doi:10.1039/d3ra03736c · Cited by 75

E-pharmacophore modelling, virtual screening, molecular dynamics simulations and in-silico ADME analysis for identification of potential E6 inhibitors against cervical cancer

Kumar, A., Rathi, E., & Kini, S. G. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.04.023 · Cited by 73

Nucleic Acid-Based Approaches for Tumor Therapy

Hager, S., Fittler, F. J., Wagner, E., & Bros, M. (2020) · Cells · doi:10.3390/cells9092061 · Cited by 78

HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition

Liebenberg, L. J. P., McKinnon, L. R., Yende‐Zuma, N., Garrett, N., Baxter, C., Kharsany, A. B. M., Archary, D., Rositch, A. F., Samsunder, N., Mansoor, L. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13089-2 · Cited by 73

Geographic and temporal variations in the incidence of vulvar and vaginal cancers

Bray, F., Laversanne, M., Weiderpass, E., & Arbyn, M. (2020) · International Journal of Cancer · doi:10.1002/ijc.33055 · Cited by 72

Evaluation of Deep Neural Networks for Semantic Segmentation of Prostate in T2W MRI

Khan, Z., Yahya, N., Alsaih, K., Ali, S. S. A., & Mériaudeau, F. (2020) · Sensors · doi:10.3390/s20113183 · Cited by 71

Pyroptosis is involved in the inhibitory effect of FL118 on growth and metastasis in colorectal cancer

Tang, Z., Ji, L., Han, M., Xie, J., Zhong, F., Zhang, X., Su, Q., Yang, Z., Liu, Z., Gao, H., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118065 · Cited by 72

Therapeutic role of curcumin and its novel formulations in gynecological cancers

Pourhanifeh, M. H., Darvish, M., Tabatabaeian, J., Fard, M. R., Mottaghi, R., Azadchehr, M. J., Jahanshahi, M., Sahebkar, A., & Mirzaei, H. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00731-7 · Cited by 72

Genomic landscape and clonal architecture of mouse oral squamous cell carcinomas dictate tumour ecology

Sequeira, I., Rashid, M., Tomás, I. M., Williams, M. J., Graham, T. A., Adams, D. J., Vigilante, A., & Watt, F. M. (2020) · Nature Communications · doi:10.1038/s41467-020-19401-9 · Cited by 75

Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer–T cell coculture models

Mimura, K., Kua, L., Xiao, J.-F., Asuncion, B. R., Nakayama, Y., Syn, N. L. X., Fazreen, Z., Soong, R. C. T., Kono, K., & Yong, W. P. (2021) · Gastric Cancer · doi:10.1007/s10120-020-01151-8 · Cited by 75

Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies

Oladejo, M., Paterson, Y. Y. W., & Wood, L. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642316 · Cited by 74

Gangliosides as Signaling Regulators in Cancer

Sasaki, N., Toyoda, M., & Ishiwata, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105076 · Cited by 72

From Microbiome to Inflammation: The Key Drivers of Cervical Cancer

Zhou, Z., Long, H., Cheng, Y., Luo, H., Wen, D., & Gao, L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.767931 · Cited by 79

Anticancer Drug-Loading Capacity of Green Synthesized Porous Magnetic Iron Nanocarrier and Cytotoxic Effects Against Human Cancer Cell Line

Ansari, M. J., Jasim, S. A., Taban, T. Z., Bokov, D. O., Shalaby, M. N., Al-Gazally, M. E., Kzar, H. H., Qasim, M. T., Mustafa, Y. F., & Khatami, M. (2022) · Journal of Cluster Science · doi:10.1007/s10876-022-02235-4 · Cited by 72

Lung cancer risk in never-smokers: An overview of environmental and genetic factors

Cheng, E. S., Weber, M. F., Steinberg, J., & Yu, X. Q. (2021) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2021.05.02 · Cited by 79

Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment

Yang, M., Qin, C., Tao, L., Cheng, G., Li, J., Lv, F., Yang, N., Xing, Z., Chu, X., Han, X., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122253 · Cited by 75

Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial

Murthy, V., Maitre, P., Bhatia, J., Kannan, S., Krishnatry, R., Prakash, G. J., Bakshi, G., Pal, M., Menon, S. G., & Mahantshetty, U. M. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.12.006 · Cited by 71

Survival-Associated Metabolic Genes in Human Papillomavirus-Positive Head and Neck Cancers

Prusinkiewicz, M. A., Gameiro, S. F., Ghasemi, F., Dodge, M. J., Zeng, P. Y., Maekebay, H., Barrett, J. W., Nichols, A. C., & Mymryk, J. S. (2020) · Cancers · doi:10.3390/cancers12010253 · Cited by 70

Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis

Linschoten, M., Kamphuis, J. A. M., van Rhenen, A., Bosman, L. P., Cramer, M. J., Doevendans, P. A., Teske, A. J., & Asselbergs, F. W. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30031-4 · Cited by 70

Hitchhiking with Nature: Snake Venom Peptides to Fight Cancer and Superbugs

Pérez‐Peinado, C., Defaus, S., & Andreu, D. (2020) · Toxins · doi:10.3390/toxins12040255 · Cited by 72

Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study

Schultheis, B. S., Strumberg, D., Kuhlmann, J. B., Wolf, M., Link, K., Seufferlein, T. T. W., Kaufmann, J., Feist, M., Gebhardt, F., Khan, M., et al. (2020) · Cancers · doi:10.3390/cancers12113130 · Cited by 71

Modern Diagnosis of Early Esophageal Cancer: From Blood Biomarkers to Advanced Endoscopy and Artificial Intelligence

Visaggi, P., Barberio, B., Ghisa, M., Ribolsi, M., Savarino, V., Fassan, M., Valmasoni, M., Marchi, S., de Bortoli, N., & Savarino, E. V. (2021) · Cancers · doi:10.3390/cancers13133162 · Cited by 70

MCRNet: Multi-level context refinement network for semantic segmentation in breast ultrasound imaging

Lou, M., Meng, J., Qi, Y., Li, X., & Ma, Y. (2021) · Neurocomputing · doi:10.1016/j.neucom.2021.10.102 · Cited by 72

Quality of life, anxiety, depression, and distress in patients with advanced and metastatic lung cancer

González-Ling, A., Vazquez, O., Bello, M. E., Robles, R., Rascón-Gasca, M. L., Lara‐Mejía, L., Heredia, D., & Arrieta, O. G. (2022) · Palliative & Supportive Care · doi:10.1017/s147895152200116x · Cited by 70

Helicobacter pylori infection facilitates cell migration and potentially impact clinical outcomes in gastric cancer

Ou, L., Liu, H., Peng, C., Zou, Y., Jia, J., Li, H., Feng, Z., Zhang, G., & Yao, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37046 · Cited by 70

microRNA: The Impact on Cancer Stemness and Therapeutic Resistance

Jiao, X., Qian, X., Wu, L., Li, B., Wang, Y., Kong, X., & Xiong, L. (2019) · Cells · doi:10.3390/cells9010008 · Cited by 68

Chinese herbal medicines for prevention and treatment of colorectal cancer: From molecular mechanisms to potential clinical applications

Kong, M., Li, L., Lou, Y.-M., Chi, H., & Wu, J. (2020) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2020.07.005 · Cited by 71

Engineered bovine serum albumin-based nanoparticles with pH-sensitivity for doxorubicin delivery and controlled release

Yang, Z., Zhang, N., Ma, T., Liu, L., Zhao, L., & Xie, H. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1797243 · Cited by 71

SAFE: A Novel Microwave Imaging System Design for Breast Cancer Screening and Early Detection—Clinical Evaluation

Janjic, A., Çayören, M., Akduman, İ., Yilmaz, T., Onemli, E., Buğdaycı, O., & Arıbal, E. (2021) · Diagnostics · doi:10.3390/diagnostics11030533 · Cited by 69

Recent insights in the PI3K/Akt pathway as a promising therapeutic target in combination with EGFR‐targeting agents to treat head and neck squamous cell carcinoma

Zaryouh, H., Pauw, I. D., Baysal, H., Peeters, M., Vermorken, J. B., Lardon, F., & Wouters, A. (2021) · Medicinal Research Reviews · doi:10.1002/med.21806 · Cited by 70

The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer – a multicentre observational study

Khadhouri, S., Gallagher, K., MacKenzie, K. R., Shah, T. T., Gao, C., Moore, S. L., Zimmermann, E. F., Edison, E., Jefferies, M. T., Nambiar, A., et al. (2021) · British Journal of Urology · doi:10.1111/bju.15483 · Cited by 69

EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA)

Bolton, R. C. D., Aide, N., Colletti, P. M., Ferrero, A., Páez, D., Skanjeti, A., & Giammarile, F. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05450-9 · Cited by 69

Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma

Jin, N., Keam, B., Cho, J., Lee, M. J., Kim, H. R., Torosyan, H., Jura, N., Ng, P. K. S., Mills, G. B., Li, H., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci150335 · Cited by 68

Deep learning for prediction of hepatocellular carcinoma recurrence after resection or liver transplantation: a discovery and validation study

Liu, Z., Liu, Y., Zhang, W., Hong, Y., Meng, J., Wang, J., Zheng, S., & Xu, X. (2022) · Hepatology International · doi:10.1007/s12072-022-10321-y · Cited by 69

Global patterns of non‐Hodgkin lymphoma in 2020

da Costa, A. M., Laversanne, M., Gospodarowicz, M. K., Klinger, P. H. D. S., Silva, N. D. P., Piñeros, M., Steliarova‐Foucher, E., Bray, F., & Znaor, A. (2022) · International Journal of Cancer · doi:10.1002/ijc.34163 · Cited by 69

Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel

Yu, Z., Li, X., Duan, J., & Yang, X. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s267177 · Cited by 70

Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis

Faraji, A., Bakhshaiesh, T. O., Hasanvand, Z., Motahari, R., Nazeri, E., Boshagh, M. A., Firoozpour, L., Mehrabi, H., Khalaj, A., Esmaeili, R., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112942 · Cited by 68

Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivo

Zhang, M., Wang, R., Tian, J., Song, M., Zhao, R., Liu, K., Zhu, F., Shim, J., Dong, Z., & Lee, M. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16568 · Cited by 68

Clinical Activity and Safety of Penpulimab (Anti-PD-1) With Anlotinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: An Open-Label, Multicenter, Phase Ib/II Trial (AK105-203)

Han, C., Ye, S., Hu, C., Shen, L., Qin, Q., Bai, Y., Yang, S., Bai, C., Zang, A., Jiao, S., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.684867 · Cited by 68

A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma

Luo, L., Li, L., Liu, L., Feng, Z., Zeng, Q., Shu, X., Cao, Y., & Li, Z. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.833928 · Cited by 69

Phenolic Phytochemicals for Prevention and Treatment of Colorectal Cancer: A Critical Evaluation of In Vivo Studies

De, S., Paul, S., Manna, A., Majumder, C., Pal, K., Casarcia, N., Mondal, A., Banerjee, S., Nelson, V. K., Ghosh, S., et al. (2023) · Cancers · doi:10.3390/cancers15030993 · Cited by 70

PFKFB3 inhibitors as potential anticancer agents: Mechanisms of action, current developments, and structure-activity relationships

Wang, Y., Qu, C., Liu, T., & Wang, C. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112612 · Cited by 69

Neoadjuvant Chemotherapy Increases PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma

Fukuoka, E., Yamashita, K., Tanaka, T., Sawada, R., Sugita, Y., Arimoto, A., Fujita, M., Takiguchi, G., Matsuda, T., Oshikiri, T., et al. (2019) · Anticancer Research · doi:10.21873/anticanres.13631 · Cited by 66

Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer

Li, D., Zhang, L., Liu, Y., Sun, H., Onwuka, J. U., Zhao, Z., Tian, W., Xu, J., Zhao, Y., & Xu, J. (2019) · Aging · doi:10.18632/aging.102569 · Cited by 67

Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario

Vanni, G., Pellicciaro, M., Materazzo, M., Bruno, V., Oldani, C., Pistolese, C. A., BUONOMO, C., CASPI, J., Gualtieri, P., Chiaravalloti, A., et al. (2020) · In Vivo · doi:10.21873/invivo.12139 · Cited by 67

Dietary isothiocyanates inhibit cancer progression by modulation of epigenome

Sundaram, M. K., Preetha, R., Haque, S., Akhter, N., Khan, S. A., Ahmad, S., & Hussain, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.021 · Cited by 67

Contemporary management of breast cancer in Nigeria: Insights from an institutional database

Olasehinde, O. O., Alatise, O. I., Omisore, A. D., Wuraola, F. O., Odujoko, O. O., Romanoff, A. M., Akinkuolie, A. A., Arowolo, O. A., Adisa, A., Knapp, G., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33484 · Cited by 67

Dendrimers based cancer nanotheranostics: An overview

Saluja, V., Mishra, Y., Mishra, V. K., Giri, N., & Nayak, P. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120485 · Cited by 68

Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate Cancer

Kumaraswamy, A., Leng, K. W., Westbrook, T. C., Yates, J. A., Zhao, S. G., Evans, C. P., Feng, F. Y.-C., Morgan, T. M., & Alumkal, J. J. (2021) · European Urology · doi:10.1016/j.eururo.2021.03.005 · Cited by 67

Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030?

Amponsah‐Dacosta, E. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i36.6025 · Cited by 70

Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer

Zhu, S., Ma, A.-H., Zhu, Z. G., Adib, E., Rao, T., Li, N., Ni, K., Chittepu, V. C. S. R., PRABHALA, R. H., Risco, J. G., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002917 · Cited by 66

Multiplexed nanomaterial-assisted laser desorption/ionization for pan-cancer diagnosis and classification

Zhang, H., Zhao, L., Jiang, J., Zheng, J., Yang, L., Li, Y., Zhou, J., Liu, T., Xu, J., Lou, W., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-26642-9 · Cited by 67

Antibody-drug conjugates: the paradigm shifts in the targeted cancer therapy

Aggarwal, D., Yang, J., Salam, M. A., Sengupta, S., Al-Amin, M. Y., Mustafa, S., Khan, M. A., Huang, X., & Pawar, J. S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1203073 · Cited by 72

Molybdenum’s Role as an Essential Element in Enzymes Catabolizing Redox Reactions: A Review

Adamus, J. P., Ruszczyńska, A., & Wyczałkowska-Tomasik, A. (2024) · Biomolecules · doi:10.3390/biom14070869 · Cited by 68

PVT1 Long Non-coding RNA in Gastrointestinal Cancer

Martínez‐Barriocanal, Á., Arango, D., & Dopeso, H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00038 · Cited by 69

Validity and reliability of State-Trait Anxiety Inventory in Danish women aged 45 years and older with abnormal cervical screening results

Gustafson, L. W., Gabel, P., Hammer, A., Lauridsen, H. H., Petersen, L. K., Andersen, B. S., Bor, P., & Larsen, M. B. (2020) · BMC Medical Research Methodology · doi:10.1186/s12874-020-00982-4 · Cited by 69

Germline genetic variability in pancreatic cancer risk and prognosis

Gentiluomo, M., Canzian, F., Nicolini, A., Gemignani, F., Landi, S., & Campa, D. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.08.003 · Cited by 68

Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma

Mito, I., Takahashi, H., Kawabata‐Iwakawa, R., Ida, S., Tada, H., & Chikamatsu, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-95718-9 · Cited by 66

Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer

Girisa, S., Henamayee, S., Parama, D., Rana, V., Dutta, U., & Kunnumakkara, A. B. (2021) · Molecular Biomedicine · doi:10.1186/s43556-021-00035-2 · Cited by 67

Odors and cancer: Current status and future directions

Gouzerh, F., Bessière, J., Újvári, B., Frédéric Thomas, A., Dujon, A. M., & Dormont, L. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188644 · Cited by 66

Indoor Tanning and the Risk of Overall and Early-Onset Melanoma and Non-Melanoma Skin Cancer: Systematic Review and Meta-Analysis

An, S., Kim, K., Moon, S., Ko, K., Kim, I., Lee, J. E., & Park, S. K. (2021) · Cancers · doi:10.3390/cancers13235940 · Cited by 66

Tumor buster - where will the CAR-T cell therapy ‘missile’ go?

Qu, C., Zhang, H., Cao, H., Tang, L., Mo, H., Liu, F., Zhang, L., Yi, Z., Long, L., Yan, L., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01669-8 · Cited by 68

Melatonin and erastin emerge synergistic anti-tumor effects on oral squamous cell carcinoma by inducing apoptosis, ferroptosis, and inhibiting autophagy through promoting ROS

Wang, L., Wang, C., Li, X., Tao, Z.-Y., Zhu, W., Su, Y., & Choi, W. S. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00449-6 · Cited by 67

Advanced network pharmacology study reveals multi-pathway and multi-gene regulatory molecular mechanism of Bacopa monnieri in liver cancer based on data mining, molecular modeling, and microarray data analysis

Sadaqat, M., Qasim, M., Qamar, M. T. U., Masoud, M. S., Ashfaq, U. A., Noor, F., Fatima, K., Allemailem, K. S., Alrumaihi, F., & Almatroudi, A. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107059 · Cited by 66

Global patterns and trends in Kaposi sarcoma incidence: a population-based study

Fu, L., Tian, T., Wang, B., Lu, Z., Gao, Y., Sun, Y., Lin, Y., Zhang, W., Li, Y., & Zou, H. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00349-2 · Cited by 66

Bioactivity Profile of the Diterpene Isosteviol and its Derivatives

Ullah, A., Munir, S., Mabkhot, Y. N., & Badshah, S. L. (2019) · Molecules · doi:10.3390/molecules24040678 · Cited by 67

Inula Viscosa Extract Inhibits Growth of Colorectal Cancer Cells in vitro and in vivo Through Induction of Apoptosis

Bar‐Shalom, R., Bergman, M., Grossman, S., Azzam, N., Sharvit, L. E., & Fares, F. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00227 · Cited by 69

Dietary Compound Isoliquiritigenin, an Antioxidant from Licorice, Suppresses Triple-Negative Breast Tumor Growth via Apoptotic Death Program Activation in Cell and Xenograft Animal Models

Lin, P., Chiang, Y., Shieh, T., Chen, H.-Y., Shih, C., Wang, T., Wang, K.-L., Huang, T., Hong, Y.-H., Li, S., et al. (2020) · Antioxidants · doi:10.3390/antiox9030228 · Cited by 65

Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance

Dzobo, K., & Dandara, C. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2020.0023 · Cited by 65

Characterization of the Esophageal Microbiota and Prediction of the Metabolic Pathways Involved in Esophageal Cancer

Li, D., He, R., Hou, G., Ming, W., Fan, T. T., Chen, L., Zhang, L., Jiang, W., Wang, W., Lu, Z., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00268 · Cited by 65

Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine

Rahat, B., Ali, T., Sapehia, D., Mahajan, A., & Kaur, J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00844 · Cited by 67

The Roadmap of Colorectal Cancer Screening

Ferlizza, E., Solmi, R., Sgarzi, M., Ricciardiello, L., & Lauriola, M. (2021) · Cancers · doi:10.3390/cancers13051101 · Cited by 65

Long Noncoding RNA HCP5 Regulates Pancreatic Cancer Gemcitabine (GEM) Resistance By Sponging Hsa-miR-214-3p To Target HDGF

Liu, Y., Wang, J., Dong, L., Li, X., Zhu, H., Li, Z., & Xiao, Y. P. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s222703 · Cited by 64

Breast cancer burden in Africa: evidence from GLOBOCAN 2018

Sharma, R. (2020) · Journal of Public Health · doi:10.1093/pubmed/fdaa099 · Cited by 64

Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)

Robijns, J., Lodewijckx, J., Claes, S., Bever, L. V., Pannekoeke, L., Censabella, S., Bussé, L., Colson, D., Kaminski, I., Broux, V., et al. (2021) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2021.03.002 · Cited by 64

Current and projected number of years of life lost due to prostate cancer: A global study

Withrow, D. R., Pilleron, S., Nikita, N., Ferlay, J., Sharma, S., Nicholson, B. D., Rebbeck, T. R., & Lu-Yao, G. L. (2022) · The Prostate · doi:10.1002/pros.24360 · Cited by 64

Pyroptosis Provides New Strategies for the Treatment of Cancer

Jia, Y., Wang, X., Deng, Y., Li, S., Xu, X., Qin, Y., & Peng, L. J. (2023) · Journal of Cancer · doi:10.7150/jca.77965 · Cited by 66

IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatment

Song, M., Liang, J., Wang, L., Li, W., Jiang, S., Xu, S., Tang, L., Du, Q., Liu, G., Meng, H., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110757 · Cited by 71

Anticancer activity of quantum size carbon dots: opportunities and challenges

Bhattacharya, T., Preetam, S., Mukherjee, S., Kar, S., Roy, D. S., Singh, H., Ghose, A., Das, T., & Mohapatra, G. (2024) · Discover Nano · doi:10.1186/s11671-024-04069-7 · Cited by 71

Targeting Redox Metabolism in Pancreatic Cancer

Hadi, N. A., Reyes‐Castellanos, G., & Carrier, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041534 · Cited by 63

KEYNOTE-859: a Phase III Study of Pembrolizumab Plus Chemotherapy in Gastric/Gastroesophageal Junction Adenocarcinoma

Tabernero, J. M., Bang, Y., Cutsem, E. V., Fuchs, C. S., Janjigian, Y. Y., Bhagia, P., Li, K., Adelberg, D. E., & Qin, S. (2021) · Future Oncology · doi:10.2217/fon-2021-0176 · Cited by 63

Antiproliferation Activity and Apoptotic Mechanism of Soursop (Annona muricata L.) Leaves Extract and Fractions on MCF7 Breast Cancer Cells

Hadisaputri, Y. E., Habibah, U., Abdullah, F. F., Halimah, E., Mutakin, M., Megantara, S., Abdulah, R., & Diantini, A. (2021) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s317682 · Cited by 70

Obesity and gynecological cancers: A toxic relationship

Wichmann, I. A., & Cuello, M. A. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13870 · Cited by 63

COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer

Owusu-Ansah, K. G., Song, G., Chen, R., Edoo, M. I. A., Li, J., Chen, B., Wu, J., Zhou, L., Xie, H., Jiang, D., et al. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4825 · Cited by 62

Cancer Stem Cells: Powerful Targets to Improve Current Anticancer Therapeutics

Bighetti‐Trevisan, R. L., Sousa, L. O., CASTILHO, R. M., & Almeida, L. O. (2019) · Stem Cells International · doi:10.1155/2019/9618065 · Cited by 64

Biological effects of corosolic acid as an anti-inflammatory, anti-metabolic syndrome and anti-neoplasic natural compound.

Zhao, J.-W., Zhou, H., An, Y., Shen, K., & Yu, L. (2020) · Oncology Letters · doi:10.3892/ol.2020.12345 · Cited by 60

Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression

Kemper, M., Schiecke, A., Maar, H., Nikulin, S. V., Poloznikov, A. A., Galatenko, V., Tachezy, M., Gebauer, F., Lange, T., Riecken, K., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01946-2 · Cited by 61

Moringa oleifera : a systematic review of its botany, traditional uses, phytochemistry, pharmacology and toxicity

Liu, R., Liu, J., Huang, Q., Shao, L., & Jiang, Y. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab131 · Cited by 62

Recent Advances and Emerging Trends in Cancer Biomarker Detection Technologies

Kumar, R. K. R., Kumar, A., Chuang, C.-H., & Shaikh, M. O. (2023) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.2c04097 · Cited by 62

GLOBOCAN 2018: counting the toll of cancer

Lancet, T. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32252-9 · Cited by 253

The new GLOBOCAN methods paper demonstrates global inequalities in data sources

Hemminki, K., & Kaaks, R. (2024) · International Journal of Cancer · doi:10.1002/ijc.35300

Cancer statistics for the year 2020: An overview

Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 6,308

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109